BrdU


Manufacturer	GENWAY
Category	Oncology Antibodies Cell Biology Cell Status Apoptosis Flow Cytometry Immunohistochemistry Primary Antibodies By Organ Heart & Blood Cancer
Type	Antibody
Specific against	other
Clone	Bu20a
Applications	FC, IHC
Amount	0.02 mg
Item no.	20-783-310522
eClass 6.1	32160702
eClass 9.0	32160702
Available
Genway ID:	GWB-4088D4
Specificity:	BrdU
Specificity:	BrdU
Clone:	Bu20a
Immunogen:	Bromodeoxyuridine conjugated to BSA.
Fusion Partner:	Spleen cells from immunised Balb/c mice were fused with cells of the NS1 myeloma cell line.
Specificity Note:	This product recognises the thymidine analogue bromodoxyuridine (BrdU) which can be incorporated into DNA during S-phase of the cell cycle. The BU20a antibody is suitable for detecting incorporated BrdU in a wide variety of cell types and is suitable for use on tissue sections in double-labelling techniques.
Preparation:	Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
Buffer Solution:	Phosphate buffered saline pH7. 4
Preservative Stabilisers:		0. 09%Sodium Azide (NaN3) Suggested
Flow Cytometry:	Use 10ul of the suggested working dilution to label 1x106 cells in 100ul. Special conditions are required for this applicationSuggested
Dilution:	Flow Cytometry - 1/25 - 1/100 1. Magaud. J. P. et al. (1989) Double Immunocytochemical labelling of cell and tissue samples with monoclonal anti-bromodeoxyuridine.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.02 mg

available

Delivery expected until 5/30/2024